文章摘要
周 元.浙江省生物医药产业链创新发展特征研究[J].全球科技经济瞭望,2019,34(5):41~47
浙江省生物医药产业链创新发展特征研究
Research on the Characteristics of Innovation-driven Development of the Biomedical Industry Chain in Zhejiang
投稿时间:2019-04-22  修订日期:2019-04-22
DOI:10.3772/j.issn.1009-8623.2019.05.006
中文关键词: 生物医药产业链;随机效应模型;研发经费投入;技术开发;成果转化
英文关键词: biomedical industry chain; random effects model; R&D expenditure; technology development; transformation of scientific and technological achievements
基金项目:浙江省软科学研究计划项目“新经济模式下浙江生物医药产业链的结构特征与培育发展研究”(2017C35075);“智江南” 智库的相关成果。
作者单位
周 元  
摘要点击次数: 1732
全文下载次数: 981
中文摘要:
      本文对生物医药产业链的要素组成、基本特征和创新环节进行了理论分析,基于 2014—2017年浙江省生物医药高新技术企业的面板数据,采用随机效应模型,分别研究生物医药各行业的研发经费投入对技术开发环节和成果转化环节的影响,以及营业规模与两个环节的关系。结果表明,研发经费投入对化学药、生物药、中药、医疗器械 4个子行业的技术开发环节和成果转化环节均有显著正向影响,对生物药的成果转化环节在 10%水平下显著;主营业务收入对 4个子行业的成果转化均有显著正向影响,而技术开发和营业规模关系不显著。据此对浙江省生物医药产业链创新发展提出政策建议。
英文摘要:
      This paper analyzes the element composition, basic characteristics and innovation links of the biomedical industry chain based on the panel data of biomedical high-tech enterprises in Zhejiang, China, from 2014 to 2017. The random effects model is used to study the impact of R&D expenditure on technological development and results transformation links and their relationship with business scale in four sub-sectors, namely chemical medicines, biological medicines, traditional Chinese medicines and medical devices. The results show that the R&D expenditure has a significantly positive impact on both technological development and results transformation of the four sectors, which is significant at the 10% level in biological medicines. Prime operating revenue has a significantly positive impact on results transformation of the four sectors, but there is no significant correlation between technological development and business scale. Based on this study, policy recommendations are proposed for the innovation-driven development of the biomedical industry chain in Zhejiang.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮